Sutcliffe Joyce A. 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed May 17, 2013
Insider Transaction Report
Form 4
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
- Award
Employee Stock Option (right to buy)
2013-05-15+70,913→ 70,913 totalExercise: $7.94Exp: 2023-05-14→ Common Stock (70,913 underlying)
Footnotes (1)
- [F1]Vests as to 25% of the shares on 5/15/2014. Further vests as to an additional 6.25% of the original grant on 8/15/2014 and at the end of each successive three-month period thereafter until 5/15/2017.